Patients call for wider range of drug reimbursement

About 80 percent of liver cancer patients in China would like to see a wider range of treatments included in the reimbursement lists of basic medical insurance programs, according to a survey of 300 family members of liver cancer patients nationwide.

More than half of those surveyed said the patients are most in need of drugs that can effectively relieve pain and prolong life, according to the online survey, which was conducted by Life Times, a health newspaper in Beijing, in February and March.

The results were published last month.